Robin Melvin
About Robin A. Melvin
Independent director of BNY Mellon Strategic Municipals, Inc. (LEO), serving since 1995 and designated as a VMTP Shares Designee; age 61 as of the 2025 proxy . She is classified as independent (not an “interested person” under the 1940 Act), consistent with a board composed entirely of independent directors . Background spans investment banking at Goldman Sachs and extensive non-profit leadership and governance across youth mentoring and healthcare organizations, plus trustee roles at two HPS business development companies .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Boisi Family Foundation | Director; managed Family Office interface with investment managers and advisors | 1995–2012 | Primary interface with investment managers, legal advisors, and other service providers |
| MENTOR (national nonprofit) | Executive Director (NYC affiliate); VP (national affiliate network); VP of Development; Senior VP (strategy) | n/a (prior to 2013) | Led strategy and development; national network leadership |
| Mentor Illinois | Co-Chair; Board Member | Co-Chair 2014–Mar 2020; Board 2013–Mar 2020 | Increased quantity/quality of mentoring services in Illinois |
| JDRF | Board Member | Jun 2021–Jun 2022 | Nonprofit governance |
| Goldman Sachs Group, Inc. | Investment banker | n/a | Finance and capital markets experience |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| HPS Corporate Lending Fund (BDC) | Trustee | Aug 2021–Present | Closed-end management investment company regulated as a BDC |
| HPS Corporate Capital Solutions Fund (BDC) | Trustee | Dec 2023–Present | Closed-end management investment company regulated as a BDC |
| Northwestern Memorial Hospital | Director, Board of Directors | Mar 2024–Present | Academic medical center governance |
| Westover School | Trustee | 2019–Jun 2023 | Private girls’ boarding school |
Board Governance
- Independence: Entire LEO board (including chair) is independent; none of the continuing directors are “interested persons” under the 1940 Act .
- VMTP Shares Designee: Melvin is a Class II Director designated by VMTP preferred holders (distinct shareholder constituency) .
- Committees: Fund has Audit, Nominating, Compensation, and Litigation committees comprised of independent directors; Audit Committee consists of all directors; Compensation excludes the chair (DiMartino) . Audit Committee chair is Alan H. Howard; Melvin is a member (not chair) .
- Attendance: Directors (including Melvin) attended at least 75% of board and committee meetings in FY 2024; there is no formal policy for annual meeting attendance and directors did not attend last year’s annual meeting .
- Meetings held (FY 2024): Board (5), Audit (6), Compensation (1), Nominating (1); Litigation Committee did not meet .
Committee Assignments
| Committee | Membership | Chair |
|---|---|---|
| Audit | Member (Audit Committee comprises all directors) | Alan H. Howard |
| Compensation | Member (comprised of independent directors; DiMartino excluded) | Not disclosed |
| Nominating | Member (comprised of independent directors) | Not disclosed |
| Litigation | Member (comprised of independent directors) | Not disclosed |
Fixed Compensation
| Metric | FY 2024 | Notes |
|---|---|---|
| Compensation from LEO (cash) | $9,670 | Annual retainer and meeting fees allocated by net assets; expenses reimbursed |
| Aggregate compensation (Fund Complex) | $675,700 (across 68 portfolios) | BNY Mellon Family of Funds portfolios served |
| Bonus/Pension/Retirement plan | None | Fund does not have bonus, pension, profit-sharing, or retirement plan |
| Chair premium | Not applicable | Only chair (DiMartino) receives +25% compensation; Melvin not chair |
Performance Compensation
| Component | Disclosure | Details |
|---|---|---|
| Annual/Target bonus | None | Fund states no bonus program for directors |
| Stock awards (RSUs/PSUs) | Not disclosed | Proxy describes director pay as retainer/meeting fees; no equity programs outlined |
| Option awards | Not disclosed | No option program described for directors |
| Performance metrics tied to pay | Not disclosed | No revenue/EBITDA/TSR metrics disclosed for director compensation |
| Clawbacks | Not disclosed | No clawback provisions noted for director compensation in proxy |
| Change-of-control, severance | Not disclosed | No severance or CIC terms for directors disclosed |
| Tax gross-ups | Not disclosed | No gross-ups disclosed |
Other Directorships & Interlocks
| Company/Entity | Type | Role | Tenure |
|---|---|---|---|
| HPS Corporate Lending Fund | BDC | Trustee | Aug 2021–Present |
| HPS Corporate Capital Solutions Fund | BDC | Trustee | Dec 2023–Present |
| Northwestern Memorial Hospital | Nonprofit/Academic Medical Center | Director | Mar 2024–Present |
| Westover School | Private school | Trustee | 2019–Jun 2023 |
Expertise & Qualifications
- Finance and capital markets: former investment banker at Goldman Sachs .
- Nonprofit governance and strategy: senior leadership roles at MENTOR; governance at Mentor Illinois and JDRF; trustee roles at Westover School and Northwestern Memorial Hospital .
- Investment company oversight: long-tenured fund director at LEO and trustee at two HPS BDCs .
- VMTP preferred holder representation experience (as designated director) .
Equity Ownership
| Item | Value | Notes |
|---|---|---|
| LEO Common Stock beneficially owned | None | No Common Stock or VMTP shares owned as of Apr 10, 2025 |
| Shares outstanding (Common) | 62,290,854 | As of Apr 10, 2025 |
| Ownership as % of outstanding | 0.00% | Based on zero shares owned and shares outstanding |
| Aggregate holdings in BNY Mellon Family of Funds | $10,001–$50,000 | Across fund complex, not specific to LEO |
| Pledging/Hedging | Not disclosed | No pledging/hedging disclosures noted |
Governance Assessment
- Independence and oversight: Melvin is independent under the 1940 Act; the board is fully independent, with an Audit Committee comprising all directors and independent legal counsel access, indicating a robust oversight framework .
- Committee engagement: Member of the Audit Committee (chair is Howard) and, by structure, of other independent committees; FY 2024 attendance met the ≥75% threshold, with active meeting cadence (5 board; 6 audit) .
- Ownership alignment: She holds no LEO common or preferred shares, which may be viewed by some investors as lower direct “skin-in-the-game,” though she holds positions across the broader BNY fund family .
- Constituency representation: As a VMTP Shares Designee, she represents preferred shareholder interests, which can be beneficial for capital structure governance but may reflect differing priorities from common holders in certain scenarios .
- Pay structure: Director compensation is cash-based (retainers/meeting fees); no bonus, pension, or equity programs are disclosed, reducing pay-for-performance concerns but also limiting direct equity alignment .
- Engagement signal: The fund reports directors did not attend last year’s annual meeting; while there is no formal policy, some investors may prefer visible director presence at annual meetings .
Overall, Melvin’s long tenure (since 1995), independent status, and broad committee participation support board continuity and oversight at LEO; investors should weigh the lack of LEO share ownership and VMTP-designee status in assessing alignment and constituency representation .